[Letter: Therapeutic defibrination with Ancrod].
D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D057487:Enzyme Therapy; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006460:Hemolysin Proteins / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D014688:Venoms / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D006460:Hemolysin Proteins; D014688:Venoms
Therapeutische Defibrinierung mit Ancrod.